| Brenda Aponte, APRN BC NRS PRACT | |
|
10 Casia Street, San Juan, PR 00921-3201 | |
| (787) 541-7582 | |
| Not Available |
| Full Name | Brenda Aponte |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Adult Health |
| Location | 10 Casia Street, San Juan, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821104878 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 1088 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Aponte, APRN BC NRS PRACT 868 Paganini, San Juan, PR 00924 Ph: () - | Brenda Aponte, APRN BC NRS PRACT 10 Casia Street, San Juan, PR 00921-3201 Ph: (787) 541-7582 |
News Archive
Agence France-Presse examines how officials in the Indian state of Jammu and Kashmir are battling a "shocking rise in female foeticide" by seizing unlicensed ultrasound machines and enlisting the assistance of religious leaders in the country's only Muslim-majority state.
Researchers at Benaroya Research Institute at Virginia Mason used cutting-edge tetramer technology developed at BRI to find the T cells that drive rheumatoid arthritis (RA). "By using tetramer technology, we were able to examine whether T cells in people with rheumatoid arthritis were increased in number or were unique in other ways," says BRI Associate Director Jane Buckner, MD, who led the study with BRI Tetramer Core Laboratory Manager Eddie James, PhD.
A new hand-held device called the Electronic Nose, which has the potential to diagnose tuberculosis (TB) in symptomatic patients, was awarded a $950,000 grant from Grand Challenges Canada and the Bill & Melinda Gates Foundation today to support further development and testing of this ground-breaking technology.
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
Diminishing levels of GABA, the primary inhibitory neurotransmitter in the brain, may play a role in cognitive decline as we age, according to a study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
› Verified 6 days ago
Mr. Ruben Padilla, FNP - BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 | |
Mrs. Wilda Enid Montero, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 Fax: 787-641-4566 | |
Mr. Luis M. Cabret, APRN FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 456 Calle Pachin Marin, San Juan, San Juan, PR 00917 Phone: 787-993-1755 | |
Karla R Toledo Mercado, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2 Cond Jard San Francisco Apt 301, San Juan, PR 00927 Phone: 939-400-7086 | |
Mildred Negron, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1462 Calle Prof Augusto Rodriguez, San Juan, PR 00909 Phone: 787-641-1616 Fax: 787-726-7970 | |
Caleb Correa Cortes, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 | |
Rosemarie Rodriguez - Vargas, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 10 Calle Casia, San Juan, PR 00921 Phone: 787-641-7582 |